Paediatric Enterococcal Bacteremia: An Exploration of the Clinical Impact With Emphasis on Antibiotic Resistance
Antibiotic resistance in enterococci is common in children with underlying diseases and HAIs. The early empirical glycopeptide therapy consideration for high-risk patients is supported by the prevalence of ampicillin resistance. These findings underline the importance of continuous local surveillance to guide appropriate empiric antibiotic selection and highlight the need for further research into long-term resistance trends and paediatric-specific treatment strategies.
Authors
- Eda Karadağ Öncel (ORCID: https://orcid.org/0000-0001-6488-8641)
- Nurşen Belet (ORCID: https://orcid.org/0000-0002-1513-1797)
- Hatice Karaoğlu Asrak (ORCID: https://orcid.org/0000-0002-4300-3311)
- İrem Ceren Erbaş (ORCID: https://orcid.org/0000-0002-8784-979X)
- Şilem Özdem Alataş (ORCID: https://orcid.org/0000-0002-2662-5039)
- Ayşe Çakıl Güzin (ORCID: https://orcid.org/0000-0003-0023-4758)
- Mahmut Cem Ergon (ORCID: https://orcid.org/0000-0002-4847-987X)
- Elif Alacam
Institutions
- Dokuz Eylül University (TR)
Publication Details
- Journal
- Journal of Paediatrics and Child Health
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1111/jpc.70180
- Primary Topic
- Streptococcal Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00